Company insight
Integrated medical injection system
Husky Technologies plays a significant role in medical injection moulding, combining precision tooling, integrated systems and data-driven service into a cohesive platform.
usky Technologies’ ICHOR Integrated Medical Injection System, built on Schöttli moulds and supported by the Advantage+Elite service layer, has advanced medical manufacturing and shown it can be deployed effectively across multiple regions and regulatory environments. This performance earned Husky the Innovation and Business Expansion awards at the 2025 Medical Device Network Excellence Awards. Husky won the Innovation Award in the Integrated Systems category for consolidating moulds, machines, controls and service into a single engineered medical injection system that improves predictability and reduces variability. It received the Business Expansion
H
Award for Multi-Region Rollout for scaling this integrated model across multiple geographies, enabling consistent deployments in both mature and emerging medical manufacturing markets.
Integrated systems improve validation Husky’s Innovation award centres on turning a traditionally fragmented moulding cell into a single engineered medical platform. Historically, manufacturers sourced machines, moulds, hot runners, auxiliaries and software from multiple vendors and then stitched them together, adding complexity, lengthening validation and blurring accountability. The ICHOR integrated medical injection system addresses this by unifying the system: Schöttli high- precision moulds, Husky injection equipment, hot runners, auxiliaries and controls under one architecture with a unified HMI. Based on its PET expertise, Husky developed the system for regulated environments, bringing the familiarity of high-volume packaging systems into a medical context without compromising traceability or compliance. This reduces process variability,
www.medicaldevice-developments.com
shortens the path to validation and enables faster achievement of stable, high-quality output.
Husky has extended its mould and process innovation into categories such as pen and auto-injectors, syringes and pre-filled syringes, blood collection tubes and femcare components. The system supports high-cavity, complex parts at high throughput while maintaining dimensional accuracy and surface quality, critical for medical consumables where margins are tight and quality requirements uncompromising. Integration is reinforced by
Advantage+Elite, embedding predictive service into the life cycle. With 24/7 remote monitoring and analytics, Husky can detect deterioration early, schedule interventions and support optimisation of OEE. This shifts uptime from reactive maintenance to a designed outcome. Adoption of Advantage+Elite has improved efficiency, reliability and part quality, positioning the ICHOR platform as a technical and financial asset. Customers report reduced scrap, more stable cycles, extended mould life and faster time-to-market. By concentrating accountability in one platform, Husky links system design directly to P&L performance.
Multi-region rollout drives capacity Husky has turned the ICHOR injection moulding system into a repeatable model for multi-region deployment, balancing reshoring in established markets with installations in high-growth regions. In the US and France, Husky’s approach has supported onshoring and capacity re-establishment. Deployments at manufacturers such as Nephron Pharmaceuticals show how integrated systems enable large-scale local production of medical consumables, improving supply resilience and reducing import dependence. In France, Husky’s return after a decade, driven by demand for full systems rather than stand-alone
tooling, highlights the strength of its integrated proposition.
In growth regions, Husky has helped customers transition from buyers to producers. In India, Kriya Medical Technologies and CML Biotech have deployed ICHOR systems with Schöttli moulds and Advantage+Elite support to establish high-volume blood collection tube production. Cycle times below 5.5 seconds and annual capacities in the hundreds of millions position these firms as competitive suppliers for domestic and export markets. Husky’s role has extended from solution definition to training and optimisation, enabling vertical integration. In Türkiye, SEM Plastik, under its SEM Biotech division, is entering blood collection tube manufacturing with deployment of the ICHOR integrated medical system. The collaboration supports diversification and strengthens Türkiye’s position in the regional medical device supply chain.
SEM Plastik selected Husky as a long- term supplier, recognising the value of the ICHOR platform and service offering. As an early adopter, it invested in a solution designed to deliver consistent quality, efficiency and regulatory compliance from day one. Husky’s Medical Tooling Centers of Excellence in Switzerland and California standardise mould design, process know-how and validation. This enables replication of high-performance solutions across geographies with consistent outcomes.
The result is a global installed base that validates both the technology and rollout model. Multi-country adoption reduces risk for new buyers and signals strong market demand. Commercially, Husky pairs equipment sales with long-term Advantage+Elite contracts, strengthening lifetime value and customer retention. ●
www.husky.co 51
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
